Warning: Olympic Banned Asthma Drug Terbutaline In Preterm Labor – Medical News Today


USA Today

Warning: Olympic Banned Asthma Drug Terbutaline In Preterm Labor
Medical News Today
Terbutaline (Brethine) is one of the most frequently used drugs in the treatment of preterm labor. A new form of giving terbutaline, the continuous subcutaneous infusion pump, allows terbutaline to be easily given around the clock without the need for
FDA warns against using asthma drug terbutaline to delay premature birthsLos Angeles Times
FDA Issues Warning on Asthma Drug in Preterm LaborMedPage Today
Asthma drug not safe for obstetric useClinical Advisor
PR Newswire (press release) –Bioscience Technology –Medscape
all 32 news articles »

View full post on asthma – Google News

FDA warns against using asthma drug terbutaline to delay premature births – Los Angeles Times


Consumer Affairs

FDA warns against using asthma drug terbutaline to delay premature births
Los Angeles Times
Terbutaline, commercially marketed as Brethine and Bricanyl, is a drug approved for the treatment of asthma and chronic obstructive pulmonary disorder, sometimes called emphysema. It relaxes bronchial tubes and is used to ease asthma symptoms.
FDA Issues Warning on Asthma Drug in Preterm LaborMedPage Today
Asthma drug not safe for obstetric useClinical Advisor
FDA Warns Against Certain Uses of Asthma Drug Terbutaline for Preterm LaborPR Newswire (press release)
Bioscience Technology –Medscape
all 25 news articles »

View full post on asthma – Google News

Asthma drug not safe for obstetric use – Clinical Advisor


Consumer Affairs

Asthma drug not safe for obstetric use
Clinical Advisor
Terbutaline is currently approved to prevent and treat bronchospasm associated with asthma, bronchitis and emphysema, but has been used for obstetric purposes including preterm labor and treating uterine hyperstimulation in hospital settings.
FDA Issues Warning on Asthma Drug in Preterm LaborMedPage Today
FDA Warns Against Certain Uses of Asthma Drug Terbutaline for Preterm LaborPR Newswire (press release)
FDA Drug Safety Communication: New warnings against use of terbutaline to Bioscience Technology
Medscape
all 22 news articles »

View full post on asthma – Google News

FDA Issues Warning on Asthma Drug in Preterm Labor – MedPage Today


MedPage Today

FDA Issues Warning on Asthma Drug in Preterm Labor
MedPage Today
Terbutaline is approved to prevent and treat bronchospasm associated with asthma, bronchitis, and emphysema, but is sometimes used off-label for treating preterm labor and uterine hyperstimulation. Terbutaline also has been used off-label over longer
FDA Warns Against Certain Uses of Asthma Drug Terbutaline for Preterm LaborPR Newswire (press release)
FDA Drug Safety Communication: New warnings against use of terbutaline to Bioscience Technology

all 18 news articles »

View full post on asthma – Google News

FDA Warns Against Certain Uses of Asthma Drug Terbutaline for Preterm Labor – PR Newswire (press release)

FDA Warns Against Certain Uses of Asthma Drug Terbutaline for Preterm Labor
PR Newswire (press release)
Terbutaline is FDA-approved to prevent and treat narrowing of the airways (bronchospasm) associated with asthma, bronchitis, and emphysema. The drug is used off-label for obstetric purposes, including treating preterm labor and treating uterine

and more »

View full post on asthma – Google News

Targacept initiates two anti-inflammatory drug studies – Pharmaceutical Business Review

Targacept initiates two anti-inflammatory drug studies
Pharmaceutical Business Review
Targacept has initiated two separate Phase II studies of its product candidate TC-6987 in disorders characterised by inflammation, in asthma and Type II
Targacept to begin Phase 2 trials of drug that could treat asthma, diabetesWinston-Salem Journal
Targacept starts new trial for diabetes drugBizjournals.com
TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and 4-traders (press release)

all 18 news articles »

View full post on asthma – Google News

Targacept to begin Phase 2 trials of drug that could treat asthma, diabetes – Winston-Salem Journal

Targacept to begin Phase 2 trials of drug that could treat asthma, diabetes
Winston-Salem Journal
Type 2 diabetes affects 198 million worldwide, and asthma affects about 65 million in just the world's seven major pharmaceutical markets — France, Germany
Targacept starts new trial for diabetes drugBizjournals.com
TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and 4-traders (press release)

all 17 news articles »

View full post on asthma – Google News

Targacept to begin phase 2 trials for its anti-inflammatory drug compound – Winston-Salem Journal

Targacept to begin phase 2 trials for its anti-inflammatory drug compound
Winston-Salem Journal
said that the studies involve its drug compound TC-6987 for disorders related to inflammation – in this instance asthma and Type 2 diabetes.
Targacept starts new trial for diabetes drugBizjournals.com
TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and 4-traders (press release)

all 13 news articles »

View full post on asthma – Google News

Targacept starts new trial for diabetes drug – Bizjournals.com

Targacept starts new trial for diabetes drug
Bizjournals.com
Targacept will take a drug it hopes will become a treatment for asthma and Type 2 diabetes into a Phase 2 clinical trial, the company has announced.
Targacept to begin phase 2 trials for its anti-inflammatory drug compoundWinston-Salem Journal
TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and 4-traders (press release)

all 12 news articles »

View full post on asthma – Google News